Praxis Precision Medicines, Inc. (PRAX)
NASDAQ: PRAX · Real-Time Price · USD
264.54
-2.04 (-0.77%)
At close: Jun 15, 2026, 4:00 PM EDT
262.90
-1.64 (-0.62%)
After-hours: Jun 15, 2026, 6:51 PM EDT
PRAX Market Cap
PRAX has a market cap or net worth of $7.38 billion as of June 15, 2026. Its market cap has increased by 839.23% in one year.
Market Cap
7.38B
Enterprise Value
5.93B
1-Year Change
839.23%
Ranking
Category
Stock Price
$264.54
Market Cap Chart
Since the IPO on October 16, 2020, PRAX's market cap has increased from $698.02M to $7.38B, an increase of 956.56%. That is a compound annual growth rate of 51.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 7.38B | 0.06% |
| Dec 31, 2025 | 7.37B | 397.55% |
| Dec 31, 2024 | 1.48B | 675.84% |
| Dec 29, 2023 | 190.94M | 70.27% |
| Dec 30, 2022 | 112.14M | -87.31% |
| Dec 31, 2021 | 883.49M | -58.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Halozyme Therapeutics | 8.24B |
| ABIVAX Société Anonyme | 7.85B |
| ImmunityBio | 7.44B |
| Kymera Therapeutics | 7.09B |
| Protagonist Therapeutics | 7.06B |
| TG Therapeutics | 7.02B |
| Spyre Therapeutics | 7.02B |
| Immunovant | 6.90B |